Utility of Single-Phase Computed Tomography in Identifying Parathyroid Adenomas: A Feasibility Study

Curr Probl Diagn Radiol. 2018 Mar-Apr;47(2):90-93. doi: 10.1067/j.cpradiol.2017.05.003. Epub 2017 May 17.

Abstract

Objective: We tested the hypothesis that a single-phase neck computed tomography (CT) is not inferior to multiphase neck CT (MPNCT), ultrasound, or nuclear medicine sestamibi scan in identifying parathyroid adenomas (PAs).

Methods: A total of 29 patients who had an MPNCT for the evaluation of a PA were identified; 11 patients met the inclusion criteria. During the 30-second arterial phase CT (APNCT), a normalized Hounsfield unit of suspected PA was compared to Hounsfield unit of a normal-appearing level I and a level II lymph node. A PA was defined as a lesion with a ratio of greater than 1.4 when compared to the level I and level II lymph node. This cutoff was determined based on the normalized ratios between level II and level I lymph nodes. Results of intraoperative parathyroid hormone assays and surgical pathology were used to validate the accuracy of this technique.

Results: The sensitivity of this method in APNCT is 90.9% whereas positive predictive value is 100%. The sensitivity or positive predictive value of ultrasound and nuclear medicine are 60% or 100% and 90% or 100%, respectively.

Conclusion: The sensitivity of APNCT is equivalent to that of MPNCT in identifying PA.

MeSH terms

  • Adenoma / blood
  • Adenoma / diagnostic imaging*
  • Adenoma / surgery
  • Adult
  • Aged
  • Contrast Media
  • Diagnosis, Differential
  • Feasibility Studies
  • Female
  • Humans
  • Iopamidol
  • Lymph Nodes / diagnostic imaging
  • Male
  • Middle Aged
  • Parathyroid Hormone / blood
  • Parathyroid Neoplasms / blood
  • Parathyroid Neoplasms / diagnostic imaging*
  • Parathyroid Neoplasms / surgery
  • Predictive Value of Tests
  • Retrospective Studies
  • Sensitivity and Specificity
  • Tomography, X-Ray Computed / methods*

Substances

  • Contrast Media
  • Parathyroid Hormone
  • Iopamidol